Handy Solutions Sinus Congestion and Pain Relief
- Product NDC
- 67751-178
- Requested package NDC
- 67751-178-02
- 11-digit product format
- 677510178
- Labeler code
- 67751
- Product ID
- 67751-178_f18af79a-4939-2cf2-e053-2a95a90a0205
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Navajo Manufacturing Company Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2016-10-22
- Marketing end
- 2024-07-01
- Substance
- ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 325 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67751-178 | 67751-178-02 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 67751-178 | 67751-178-02 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks DayQuil and Vicks NyQuil HIGH BLOOD PRESSURE COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efbda62c-5d1a-2026-e053-2995a90a95d7 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil HIGH BLOOD PRESSURE Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | d83c4691-785d-d1a0-e053-2995a90ad196 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil VapoCOOL COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 32819644-9f07-9f70-e063-6294a90a7223 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Kids COLD and COUGH plus FEVER | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 1a01b294-a5ee-ab35-e063-6394a90a4a1a | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Kids and Vicks NyQuil Kids COLD and COUGH plus FEVER | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 2d430264-074d-fb22-e063-6294a90a57f6 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Kids COLD and COUGH plus FEVER | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 1a01d4f7-37ed-bb92-e063-6294a90a208c | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | efb982d4-93d0-815f-e053-2995a90a82dd | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efe4e649-7514-32dd-e053-2995a90a0492 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil COLD and FLU | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efb92829-1007-1c5d-e053-2a95a90a3c9b | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 04dc3835-64be-d9e4-e063-6394a90a8599 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fc9a43d8-0359-9def-e053-6294a90a7e91 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fc9a6f7e-32c1-9ded-e053-6294a90a9dcc | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 416c6674-e4aa-6375-e054-00144ff8d46c | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fc9e05a5-ca03-faa2-e053-6294a90a0d58 | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 16272e93-0062-935a-e063-6294a90a0dda | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 17dfc247-fcb6-9659-e063-6294a90a2523 | 2026-10-05 | Warnings | M012 |
| Vicks NyQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 16275c74-32a6-25f4-e063-6394a90a6717 | 2026-10-05 | Warnings | M012 |
| Vicks VapoDrops | MENTHOL | The Procter & Gamble Manufacturing Company | 3c431baa-c49d-ff3f-e063-6394a90aa12a | 2026-10-05 | Warnings | M012 |
| VICKS FORMULA 44DM COUGH | DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 05411a51-a49a-96fd-e063-6294a90ae37b | 2026-10-05 | Warnings | M012 |
| VICKS FORMULA 44DM COUGH and CHEST CONGESTION | DEXTROMETHORPHAN HBR, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 05412b91-c1f0-c947-e063-6294a90acd17 | 2026-10-05 | Warnings | M012 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67751-178-02 | 67751017802 | 2 TABLET in 1 POUCH (67751-178-02) | 2 tablet | 2016-10-22 | 2024-07-01 | No | No | Current |